Jazz must face US antitrust claims over Xyrem, federal judge rules
MLex Summary: Jazz Pharmaceuticals must face US antitrust counterclaims filed by Avadel, a judge ruled. District Judge Gregory B. Williams found that there is a genuine dispute of material fact regarding...To view the full article, register now.
Already a subscriber? Click here to view full article